Titre : Nigella

Nigella : Questions médicales fréquentes

Termes MeSH sélectionnés :

Communication

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment diagnostiquer une allergie à Nigella ?

Un test cutané ou un test sanguin peut confirmer une allergie aux composants de Nigella.
Allergies Tests cutanés
#2

Quels tests pour évaluer l'efficacité de Nigella ?

Des études cliniques et des essais contrôlés randomisés sont nécessaires pour évaluer son efficacité.
Essais cliniques Efficacité thérapeutique

Symptômes 2

#1

Quels sont les symptômes d'une intoxication à Nigella ?

Les symptômes incluent des nausées, vomissements, et des douleurs abdominales.
Intoxication alimentaire Symptômes
#2

Nigella peut-elle provoquer des effets secondaires ?

Oui, des effets secondaires comme des troubles gastro-intestinaux peuvent survenir.
Effets indésirables Troubles gastro-intestinaux

Prévention 2

#1

Nigella peut-elle prévenir certaines maladies ?

Oui, elle est étudiée pour ses effets préventifs sur les maladies cardiovasculaires.
Prévention des maladies Maladies cardiovasculaires
#2

Comment intégrer Nigella dans l'alimentation ?

On peut ajouter les graines de Nigella dans les plats, salades ou infusions.
Nutrition Alimentation

Traitements 2

#1

Comment utiliser Nigella pour l'inflammation ?

L'huile de Nigella peut être appliquée localement ou ingérée pour réduire l'inflammation.
Anti-inflammatoires Huile essentielle
#2

Nigella est-elle efficace contre le diabète ?

Des études montrent que Nigella peut aider à réguler la glycémie chez les diabétiques.
Diabète Glycémie

Complications 2

#1

Quelles complications peuvent survenir avec Nigella ?

Des complications comme des réactions allergiques sévères peuvent survenir chez certains individus.
Réactions allergiques Complications
#2

Nigella peut-elle interagir avec des médicaments ?

Oui, elle peut interagir avec des anticoagulants et d'autres médicaments, nécessitant prudence.
Interactions médicamenteuses Anticoagulants

Facteurs de risque 2

#1

Qui devrait éviter Nigella ?

Les personnes allergiques aux plantes de la famille des renonculacées doivent l'éviter.
Allergies Renonculacées
#2

Quels sont les risques d'une surconsommation de Nigella ?

Une surconsommation peut entraîner des troubles digestifs et des effets indésirables.
Surconsommation Troubles digestifs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Nigella : Questions médicales les plus fréquentes", "headline": "Nigella : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Nigella : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-18", "dateModified": "2025-04-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Nigella" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Ranonculaceae", "url": "https://questionsmedicales.fr/mesh/D029626", "about": { "@type": "MedicalCondition", "name": "Ranonculaceae", "code": { "@type": "MedicalCode", "code": "D029626", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.836.750" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Nigella damascena", "alternateName": "Nigella damascena", "url": "https://questionsmedicales.fr/mesh/D031861", "about": { "@type": "MedicalCondition", "name": "Nigella damascena", "code": { "@type": "MedicalCode", "code": "D031861", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.836.750.518.500" } } }, { "@type": "MedicalWebPage", "name": "Nigella sativa", "alternateName": "Nigella sativa", "url": "https://questionsmedicales.fr/mesh/D031881", "about": { "@type": "MedicalCondition", "name": "Nigella sativa", "code": { "@type": "MedicalCode", "code": "D031881", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.875.800.575.912.250.836.750.518.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Nigella", "alternateName": "Nigella", "code": { "@type": "MedicalCode", "code": "D031844", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xu Yao", "url": "https://questionsmedicales.fr/author/Xu%20Yao", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China." } }, { "@type": "Person", "name": "Hongyan Shan", "url": "https://questionsmedicales.fr/author/Hongyan%20Shan", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China." } }, { "@type": "Person", "name": "Hongzhi Kong", "url": "https://questionsmedicales.fr/author/Hongzhi%20Kong", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China." } }, { "@type": "Person", "name": "Erdem Yeşilada", "url": "https://questionsmedicales.fr/author/Erdem%20Ye%C5%9Filada", "affiliation": { "@type": "Organization", "name": "Department of Pharmacognosy, Faculty of Pharmacy, Yeditepe University, 34755, Istanbul, Turkey." } }, { "@type": "Person", "name": "Xiaoshan Duan", "url": "https://questionsmedicales.fr/author/Xiaoshan%20Duan", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Communication Overload in Hospitals: Exploring Organizational Safety Communication, Worker Job Attitudes, and Communication Efficacy.", "datePublished": "2022-09-29", "url": "https://questionsmedicales.fr/article/36172847", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/10410236.2022.2129313" } }, { "@type": "ScholarlyArticle", "name": "Strategic communication as planned behavior for science and risk communication: A theory-based approach to studying communicator choice.", "datePublished": "2022-09-18", "url": "https://questionsmedicales.fr/article/36116781", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/risa.14029" } }, { "@type": "ScholarlyArticle", "name": "Communication Openings: A Novel Approach for Serious Illness Communication in Homecare.", "datePublished": "2023-11-01", "url": "https://questionsmedicales.fr/article/37906048", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3928/00989134-20231011-02" } }, { "@type": "ScholarlyArticle", "name": "Everyday Barriers in Communicative Participation According to People With Communication Problems.", "datePublished": "2023-02-14", "url": "https://questionsmedicales.fr/article/36787154", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2022_JSLHR-22-00405" } }, { "@type": "ScholarlyArticle", "name": "Beyond dyadic communication: Network of communication in inflammatory arthritis teams.", "datePublished": "2022-05-29", "url": "https://questionsmedicales.fr/article/35635126", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/17423953221102629" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Eucaryotes", "item": "https://questionsmedicales.fr/mesh/D056890" }, { "@type": "ListItem", "position": 3, "name": "Viridiplantae", "item": "https://questionsmedicales.fr/mesh/D057948" }, { "@type": "ListItem", "position": 4, "name": "Streptophyta", "item": "https://questionsmedicales.fr/mesh/D057949" }, { "@type": "ListItem", "position": 5, "name": "Embryophyta", "item": "https://questionsmedicales.fr/mesh/D019669" }, { "@type": "ListItem", "position": 6, "name": "Tracheobionta", "item": "https://questionsmedicales.fr/mesh/D064028" }, { "@type": "ListItem", "position": 7, "name": "Magnoliopsida", "item": "https://questionsmedicales.fr/mesh/D019684" }, { "@type": "ListItem", "position": 8, "name": "Ranunculales", "item": "https://questionsmedicales.fr/mesh/D000076664" }, { "@type": "ListItem", "position": 9, "name": "Ranonculaceae", "item": "https://questionsmedicales.fr/mesh/D029626" }, { "@type": "ListItem", "position": 10, "name": "Nigella", "item": "https://questionsmedicales.fr/mesh/D031844" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Nigella - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Nigella", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Nigella", "description": "Comment diagnostiquer une allergie à Nigella ?\nQuels tests pour évaluer l'efficacité de Nigella ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Communication#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Nigella", "description": "Quels sont les symptômes d'une intoxication à Nigella ?\nNigella peut-elle provoquer des effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Communication#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Nigella", "description": "Nigella peut-elle prévenir certaines maladies ?\nComment intégrer Nigella dans l'alimentation ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Communication#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Nigella", "description": "Comment utiliser Nigella pour l'inflammation ?\nNigella est-elle efficace contre le diabète ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Communication#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Nigella", "description": "Quelles complications peuvent survenir avec Nigella ?\nNigella peut-elle interagir avec des médicaments ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Communication#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Nigella", "description": "Qui devrait éviter Nigella ?\nQuels sont les risques d'une surconsommation de Nigella ?", "url": "https://questionsmedicales.fr/mesh/D031844?mesh_terms=Communication#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une allergie à Nigella ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test cutané ou un test sanguin peut confirmer une allergie aux composants de Nigella." } }, { "@type": "Question", "name": "Quels tests pour évaluer l'efficacité de Nigella ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des études cliniques et des essais contrôlés randomisés sont nécessaires pour évaluer son efficacité." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication à Nigella ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, vomissements, et des douleurs abdominales." } }, { "@type": "Question", "name": "Nigella peut-elle provoquer des effets secondaires ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des troubles gastro-intestinaux peuvent survenir." } }, { "@type": "Question", "name": "Nigella peut-elle prévenir certaines maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est étudiée pour ses effets préventifs sur les maladies cardiovasculaires." } }, { "@type": "Question", "name": "Comment intégrer Nigella dans l'alimentation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "On peut ajouter les graines de Nigella dans les plats, salades ou infusions." } }, { "@type": "Question", "name": "Comment utiliser Nigella pour l'inflammation ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "L'huile de Nigella peut être appliquée localement ou ingérée pour réduire l'inflammation." } }, { "@type": "Question", "name": "Nigella est-elle efficace contre le diabète ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent que Nigella peut aider à réguler la glycémie chez les diabétiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec Nigella ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des réactions allergiques sévères peuvent survenir chez certains individus." } }, { "@type": "Question", "name": "Nigella peut-elle interagir avec des médicaments ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut interagir avec des anticoagulants et d'autres médicaments, nécessitant prudence." } }, { "@type": "Question", "name": "Qui devrait éviter Nigella ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes allergiques aux plantes de la famille des renonculacées doivent l'éviter." } }, { "@type": "Question", "name": "Quels sont les risques d'une surconsommation de Nigella ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une surconsommation peut entraîner des troubles digestifs et des effets indésirables." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 14/04/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Xu Yao

4 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.

Hongyan Shan

4 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.

Hongzhi Kong

4 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.

Erdem Yeşilada

3 publications dans cette catégorie

Affiliations :
  • Department of Pharmacognosy, Faculty of Pharmacy, Yeditepe University, 34755, Istanbul, Turkey.

Xiaoshan Duan

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.

Rui Zhang

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.

Xuehao Fu

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, 100093, Beijing, China.
  • University of Chinese Academy of Sciences, 100049, Beijing, China.

Jie Cheng

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, 100093, Beijing, China.
  • University of Chinese Academy of Sciences, 100049, Beijing, China.

Naina Mohamed Pakkir Maideen

3 publications dans cette catégorie

Affiliations :
  • Dubai Health Authority Clinical Pharmacy Dubai United Arab Emirates.

Sharf Ilahi Siddiqui

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Jamia Millia Islamia, New Delhi 110025, India.
Publications dans "Nigella" :

Saif Ali Chaudhry

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Jamia Millia Islamia, New Delhi 110025, India. Electronic address: schaudhry@jmi.ac.in.
Publications dans "Nigella" :

Yi Yuan

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Systematic and Evolutionary Botany, CAS Center for Excellence in Molecular Plant Sciences, Institute of Botany, Chinese Academy of Sciences, Beijing, 100093, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.

Raluca Maria Pop

2 publications dans cette catégorie

Affiliations :
  • Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.

Veronica Sanda Chedea

2 publications dans cette catégorie

Affiliations :
  • Research Station for Viticulture and Enology, 515400 Blaj, Romania.

Ioana Corina Bocsan

2 publications dans cette catégorie

Affiliations :
  • Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.

Anca Dana Buzoianu

2 publications dans cette catégorie

Affiliations :
  • Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.

Mohammad Reza Khazdair

2 publications dans cette catégorie

Affiliations :
  • Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.

Mohammad Hossein Boskabady

2 publications dans cette catégorie

Affiliations :
  • Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: boskabadymh@mums.ac.ir.

Klaudia Ciesielska-Figlon

2 publications dans cette catégorie

Affiliations :
  • Department of Pathophysiology, Faculty of Medicine, Medical University of Gdansk, Poland.

Katarzyna A Lisowska

2 publications dans cette catégorie

Affiliations :
  • Department of Pathophysiology, Faculty of Medicine, Medical University of Gdansk, Poland. Electronic address: katarzyna.lisowska@gumed.edu.pl.

Sources (10000 au total)

Everyday Barriers in Communicative Participation According to People With Communication Problems.

The purpose of this study was to gain a comprehensive understanding of participation situations that are challenging for people with communication problems, to provide input for the further developmen... A purposive sampling strategy was used to include a diverse group of people with communication problems. Diaries were used as a sensitizing exercise for inductive in-depth interviews. In these intervi... Eighteen interviews yielded 44 different concepts. They were clustered in six themes, which capture the person, location, topic, mode, moment, and pace of communication. In total, 103 new items measur... This study resulted in an overview of self-reported barriers in daily communicative participation experienced by people with communication problems. These communicative participation situations can be...

Beyond dyadic communication: Network of communication in inflammatory arthritis teams.

To explore how communication is perceived and care is negotiated amongst IA healthcare teams by drawing on the perspectives of each team member.... This analysis drew on data from an ongoing three-year study exploring team-based IA care. We interviewed 11 participants including two men with IA and their family care providers and healthcare provid... Analysis revealed three themes regarding communication and care: (1) seeking/sharing information, (2) striving to coordinate unified care, and (3) providing patients a voice.... This study emphasizes the importance of understanding team dynamics beyond the dyad of patient and care provider. Negotiating power and decision-making in IA care is a dynamic process involving shifti...

Changes in the communicative skills of young people as a result of a communication training.

To analyze the effect of communication training developed for adolescents on the youth's communication skills.... Forty-one young people participated in the study and were divided into two groups. Group I received intervention - communication training for five weeks; Group II - were guided on the importance of vo... The analysis of questionnaires showed improvement in GI in two of the four skills assessed and no difference for GII. The video evaluations showed a significant difference between the groups in terms ... This study points out that the communication training method applied to young people might improve communicative skills, providing some insights into their communication strengths and potential areas ...

Effects of Aided Communication on Communicative Participation for People With Amyotrophic Lateral Sclerosis.

Many people with amyotrophic lateral sclerosis (PALS) experience speech changes, which may interfere with participation in communication situations. This study was designed to investigate the effects ... Participants with amyotrophic lateral sclerosis completed an online questionnaire in which they identified their current communication methods, rated their speech function, and rated their communicati... Communication aids appeared to support communicative participation for many participants with dysarthria. Across all levels of speech function, PALS who use aided communication reported better partici... Aided communication can help PALS continue to participate in various communication situations as their speech function deteriorates. Variability in self-rated communicative participation, even for PAL... https://doi.org/10.23641/asha.22782986....

Communication experiences of healthcare students whilst managing adults with communication disorders.

Research has found that people with communication disabilities are three times more likely to encounter medical mishaps. Almost a third of patients with speech-language therapy (SLT) diagnoses have ot... This study aims to describe the communication challenges and strategies employed by a group of final year Nursing, Medicine, Dietetics and Human Nutrition, Physiotherapy and Occupational Therapy stude... A qualitative, phenomenological study design was used. Questionnaires were electronically distributed, and results were analysed thematically.... The most significant challenges whilst managing adults with communication disorders were patients' receptive and expressive language difficulties. Further challenges included lack of knowledge surroun... This study revealed that there is a need to develop healthcare students' skills in managing adults with communication disorders. This is because of the challenges faced and inefficiency of the strateg...